Showing 151 - 160 of 287 results

Showing Results for: “Contact ”

Back to School Tips

Ensure your child's safety and well-being at school with a comprehensive Diabetes Medical Management Plan (DMMP) and a tailored 504 Plan or IEP Program.

Tips for Managing Diabetes in the Child Care Setting

Find essential tips for keeping your young child with diabetes safe and well-managed in a child care setting. Get the help you need from trusted resources.

Help for Parents

Help your child thrive at school with diabetes by learning about their rights, creating a care plan, and working with school staff to ensure a safe and supportive learning environment.

American Diabetes Association® Applauds Colorado Governor and State Legislature for Passing HB 1216: Reduce Insulin Prices Bill

On May 22, 2019, Colorado Governor Jared Polis signed the first bill in the nation that will cap insulin co-pays at $100 per month, regardless of the number of vials needed. House Bill 1216: Reduce Insulin Prices, also enlists the Colorado Attorney General to investigate the rising price of insulin in Colorado and make recommendations to the General Assembly for further action. The American Diabetes Association (ADA) applauds Governor Polis and bill sponsors, Representative Dylan Roberts and Senators Kerry Donovan and Kevin Priola, for their leadership on this important legislation to reduce

Risk of Severe Diabetes Ketoacidosis Spiked Among Pediatric Type 1 Diabetes Patients During the Pandemic

Meta-Analysis Compared Rate of Life-Threatening Diabetes Complication Among Children Prior to and During the COVID-19 Pandemic New data presented at the 82nd Scientific Sessions of the American Diabetes Association ® (ADA) revealed the incidence of severe diabetic ketoacidosis (DKA) among children with type 1 diabetes was significantly higher during the pandemic compared to pre-pandemic. DKA is a serious, life-threatening condition that can lead to diabetic coma or even death. While DKA can happen to anyone with diabetes, it is most common among people with type 1 diabetes. DKA is caused by an

Artificial Intelligence Offers Significant Rate of Remission for Type 2 Diabetes Compared to Standard Care

Whole Body Digital Twin Technology Enables Personalized Approach to Help Improve Disrupted Metabolism for Individuals with Type 2 Diabetes A new study powered by artificial intelligence (AI), Whole Body Digital Twin, reveals the highest reported rate of remission of type 2 diabetes to date. The findings were presented as a late-breaking poster session at the 82nd Scientific Sessions of the American Diabetes Association® (ADA) in New Orleans, LA. For individuals with type 2 diabetes, remission is defined as sustaining normal blood glucose (blood sugar) levels for at least three months without

American Diabetes Association Symposium to Bring to Light the Impact of Suicide and Depression on Adolescents with Type 1 Diabetes

RESCUE Advocacy Group to Share Latest Insights on Prevalence and Prevention Strategies A symposium presented by international research group, RESCUE (REducing SuiCide rates amongst individUals with diabEtes) Collaborative Community, will address the ongoing connection between suicide and people with type 1 diabetes, with the goal of highlighting available resources and key takeaways for the field. The symposium comes at a time when adolescents and young adults with type 1 diabetes are 61% more likely to say they feel suicidal than those without diabetes. Suicide and Self-Injury—Unveiling and

American Diabetes Association to Highlight Groundbreaking Diabetes Developments During Pathways Symposium

Symposium Will Feature Research on Genomic Analysis and Glucose Monitoring Technologies Today, findings from two studies funded by the ADA Pathway to Stop Diabetes ® research program highlight innovative science and the latest diabetes developments on genomic profiling and glucose control. The symposium, 2022 Pathway to Stop Diabetes, will be presented at the 82nd Scientific Sessions held by the American Diabetes Association ® (ADA) in New Orleans, LA. Genomic Profiling & Type 2 Diabetes The symposium will highlight findings from a new study, Deciphering Longitudinal Cell Type-Specific Defects

American Diabetes Association Elevates Resources on Medtronic Recalls

On October 5, 2021, Medtronic announced the expansion of two recalls on MiniMed 600 series insulin pumps for incorrect insulin dosing and remote controllers used with Paradigm and 508 MiniMed insulin pumps for potential cybersecurity risks. The U.S. Food and Drug Administration (FDA) has identified both of these as Class I recalls, the most serious type of recall. People with diabetes who are currently using a MiniMed 600 series insulin pump and are unsure if their device is affected, should refer to the Medical Device Recalls database or use the Medtronic Pump Serial Number Look-up Tool. If